326 related articles for article (PubMed ID: 21803029)
1. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
2. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.
Wagner S; Carpentier I; Rogov V; Kreike M; Ikeda F; Löhr F; Wu CJ; Ashwell JD; Dötsch V; Dikic I; Beyaert R
Oncogene; 2008 Jun; 27(26):3739-45. PubMed ID: 18212736
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin.
Yoshikawa A; Sato Y; Yamashita M; Mimura H; Yamagata A; Fukai S
FEBS Lett; 2009 Oct; 583(20):3317-22. PubMed ID: 19766637
[TBL] [Abstract][Full Text] [Related]
6. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
7. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.
Du M; Ea CK; Fang Y; Chen ZJ
Mol Cell; 2022 Jul; 82(13):2415-2426.e5. PubMed ID: 35477005
[TBL] [Abstract][Full Text] [Related]
8. Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB.
Kensche T; Tokunaga F; Ikeda F; Goto E; Iwai K; Dikic I
J Biol Chem; 2012 Jul; 287(28):23626-34. PubMed ID: 22605335
[TBL] [Abstract][Full Text] [Related]
9. NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation.
Hadian K; Griesbach RA; Dornauer S; Wanger TM; Nagel D; Metlitzky M; Beisker W; Schmidt-Supprian M; Krappmann D
J Biol Chem; 2011 Jul; 286(29):26107-17. PubMed ID: 21622571
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
[TBL] [Abstract][Full Text] [Related]
11. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
12. Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.
Shifera AS
Biochem Biophys Res Commun; 2010 Jun; 396(3):585-9. PubMed ID: 20457134
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.
Frelin C; Imbert V; Bottero V; Gonthier N; Samraj AK; Schulze-Osthoff K; Auberger P; Courtois G; Peyron JF
Cell Death Differ; 2008 Jan; 15(1):152-60. PubMed ID: 17932497
[TBL] [Abstract][Full Text] [Related]
14. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.
Zhu G; Wu CJ; Zhao Y; Ashwell JD
Curr Biol; 2007 Aug; 17(16):1438-43. PubMed ID: 17702576
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
Shifera AS
J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
[TBL] [Abstract][Full Text] [Related]
16. If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation.
Kovalenko A; Wallach D
Mol Cell; 2006 May; 22(4):433-6. PubMed ID: 16713572
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
18. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
[TBL] [Abstract][Full Text] [Related]
19. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.
Laplantine E; Fontan E; Chiaravalli J; Lopez T; Lakisic G; Véron M; Agou F; Israël A
EMBO J; 2009 Oct; 28(19):2885-95. PubMed ID: 19763089
[TBL] [Abstract][Full Text] [Related]
20. Use of fluorescence spectroscopy for quantitative investigations of ubiquitin interactions with the ubiquitin-binding domains of NEMO.
Dubosclard V; Fontan E; Agou F
Methods Mol Biol; 2015; 1280():321-37. PubMed ID: 25736758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
